Review



eo771 breast cancer cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 98
      Buy from Supplier

    Structured Review

    ATCC eo771 breast cancer cell line
    Eo771 Breast Cancer Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 222 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eo771 breast cancer cell line/product/ATCC
    Average 98 stars, based on 222 article reviews
    eo771 breast cancer cell line - by Bioz Stars, 2026-03
    98/100 stars

    Images



    Similar Products

    eo771 breast cancer cell line  (ATCC)
    98
    ATCC eo771 breast cancer cell line
    Eo771 Breast Cancer Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eo771 breast cancer cell line/product/ATCC
    Average 98 stars, based on 1 article reviews
    eo771 breast cancer cell line - by Bioz Stars, 2026-03
    98/100 stars
    		  Buy from Supplier
    eo771  (ATCC)
    98
    ATCC eo771
    Eo771, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eo771/product/ATCC
    Average 98 stars, based on 1 article reviews
    eo771 - by Bioz Stars, 2026-03
    98/100 stars
    		  Buy from Supplier
    eo771 cells  (ATCC)
    98
    ATCC eo771 cells
    (A). Tumor cells were implanted into the flank (1 x 10 6 9464D) or mammary fat pad (1 x 10 5 <t>EO771)</t> of C57BL/6 mice, enrolled when tumors reached 0.15-0.2mm 3 . Mice were treated as per the schema and sacrificed when tumors reached a size 1.5cm 3 . (B) The Kaplan-Meier survival curve of mice and tumor volume growth curve of 9464D tumor. Median Survival: Control 12d; IgG 10d; GSI 10d; aPD-1 10d; aPD-1+ GSI 10d; RT 37d; RT+ GSI 50d; RT+aPD-1 46d; RT+aPD-1+AL101 87d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (C) The Kaplan-Meier survival curve of mice and tumor volume growth curve of EO771 tumor Median Survival: Control: 14d; IgG 14.5d; GSI 18.5d; aPD-1 15d; GSI+aPD-1 10d; RT 35d; RT+ GSI 41d; RT+aPD-1 43d; RT+aPD-1+ GSI 98.5d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (D) Lungs were collected from EO771 tumor–bearing mice (n = 4–7 per group) treated as described above and sacrificed either at day 10 or at the survival endpoint. Tumor metastases were quantified using HALO image analysis, calculated as metastatic area divided by total lung area. Bars represent mean ± SD. *P<0.05, using one-way ANOVA followed by Tukey post-hoc comparisons.
    Eo771 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eo771 cells/product/ATCC
    Average 98 stars, based on 1 article reviews
    eo771 cells - by Bioz Stars, 2026-03
    98/100 stars
    		  Buy from Supplier
    eo771 crl 3461 cells  (ATCC)
    98
    ATCC eo771 crl 3461 cells
    (A). Tumor cells were implanted into the flank (1 x 10 6 9464D) or mammary fat pad (1 x 10 5 <t>EO771)</t> of C57BL/6 mice, enrolled when tumors reached 0.15-0.2mm 3 . Mice were treated as per the schema and sacrificed when tumors reached a size 1.5cm 3 . (B) The Kaplan-Meier survival curve of mice and tumor volume growth curve of 9464D tumor. Median Survival: Control 12d; IgG 10d; GSI 10d; aPD-1 10d; aPD-1+ GSI 10d; RT 37d; RT+ GSI 50d; RT+aPD-1 46d; RT+aPD-1+AL101 87d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (C) The Kaplan-Meier survival curve of mice and tumor volume growth curve of EO771 tumor Median Survival: Control: 14d; IgG 14.5d; GSI 18.5d; aPD-1 15d; GSI+aPD-1 10d; RT 35d; RT+ GSI 41d; RT+aPD-1 43d; RT+aPD-1+ GSI 98.5d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (D) Lungs were collected from EO771 tumor–bearing mice (n = 4–7 per group) treated as described above and sacrificed either at day 10 or at the survival endpoint. Tumor metastases were quantified using HALO image analysis, calculated as metastatic area divided by total lung area. Bars represent mean ± SD. *P<0.05, using one-way ANOVA followed by Tukey post-hoc comparisons.
    Eo771 Crl 3461 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eo771 crl 3461 cells/product/ATCC
    Average 98 stars, based on 1 article reviews
    eo771 crl 3461 cells - by Bioz Stars, 2026-03
    98/100 stars
    		  Buy from Supplier
    murine mammary carcinoma cell line eo771  (ATCC)
    98
    ATCC murine mammary carcinoma cell line eo771
    (A). Tumor cells were implanted into the flank (1 x 10 6 9464D) or mammary fat pad (1 x 10 5 <t>EO771)</t> of C57BL/6 mice, enrolled when tumors reached 0.15-0.2mm 3 . Mice were treated as per the schema and sacrificed when tumors reached a size 1.5cm 3 . (B) The Kaplan-Meier survival curve of mice and tumor volume growth curve of 9464D tumor. Median Survival: Control 12d; IgG 10d; GSI 10d; aPD-1 10d; aPD-1+ GSI 10d; RT 37d; RT+ GSI 50d; RT+aPD-1 46d; RT+aPD-1+AL101 87d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (C) The Kaplan-Meier survival curve of mice and tumor volume growth curve of EO771 tumor Median Survival: Control: 14d; IgG 14.5d; GSI 18.5d; aPD-1 15d; GSI+aPD-1 10d; RT 35d; RT+ GSI 41d; RT+aPD-1 43d; RT+aPD-1+ GSI 98.5d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (D) Lungs were collected from EO771 tumor–bearing mice (n = 4–7 per group) treated as described above and sacrificed either at day 10 or at the survival endpoint. Tumor metastases were quantified using HALO image analysis, calculated as metastatic area divided by total lung area. Bars represent mean ± SD. *P<0.05, using one-way ANOVA followed by Tukey post-hoc comparisons.
    Murine Mammary Carcinoma Cell Line Eo771, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine mammary carcinoma cell line eo771/product/ATCC
    Average 98 stars, based on 1 article reviews
    murine mammary carcinoma cell line eo771 - by Bioz Stars, 2026-03
    98/100 stars
    		  Buy from Supplier
    105 eo771 luminal b tumors  (ATCC)
    98
    ATCC 105 eo771 luminal b tumors
    (A). Tumor cells were implanted into the flank (1 x 10 6 9464D) or mammary fat pad (1 x 10 5 <t>EO771)</t> of C57BL/6 mice, enrolled when tumors reached 0.15-0.2mm 3 . Mice were treated as per the schema and sacrificed when tumors reached a size 1.5cm 3 . (B) The Kaplan-Meier survival curve of mice and tumor volume growth curve of 9464D tumor. Median Survival: Control 12d; IgG 10d; GSI 10d; aPD-1 10d; aPD-1+ GSI 10d; RT 37d; RT+ GSI 50d; RT+aPD-1 46d; RT+aPD-1+AL101 87d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (C) The Kaplan-Meier survival curve of mice and tumor volume growth curve of EO771 tumor Median Survival: Control: 14d; IgG 14.5d; GSI 18.5d; aPD-1 15d; GSI+aPD-1 10d; RT 35d; RT+ GSI 41d; RT+aPD-1 43d; RT+aPD-1+ GSI 98.5d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (D) Lungs were collected from EO771 tumor–bearing mice (n = 4–7 per group) treated as described above and sacrificed either at day 10 or at the survival endpoint. Tumor metastases were quantified using HALO image analysis, calculated as metastatic area divided by total lung area. Bars represent mean ± SD. *P<0.05, using one-way ANOVA followed by Tukey post-hoc comparisons.
    105 Eo771 Luminal B Tumors, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/105 eo771 luminal b tumors/product/ATCC
    Average 98 stars, based on 1 article reviews
    105 eo771 luminal b tumors - by Bioz Stars, 2026-03
    98/100 stars
    		  Buy from Supplier

    Image Search Results


    (A). Tumor cells were implanted into the flank (1 x 10 6 9464D) or mammary fat pad (1 x 10 5 EO771) of C57BL/6 mice, enrolled when tumors reached 0.15-0.2mm 3 . Mice were treated as per the schema and sacrificed when tumors reached a size 1.5cm 3 . (B) The Kaplan-Meier survival curve of mice and tumor volume growth curve of 9464D tumor. Median Survival: Control 12d; IgG 10d; GSI 10d; aPD-1 10d; aPD-1+ GSI 10d; RT 37d; RT+ GSI 50d; RT+aPD-1 46d; RT+aPD-1+AL101 87d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (C) The Kaplan-Meier survival curve of mice and tumor volume growth curve of EO771 tumor Median Survival: Control: 14d; IgG 14.5d; GSI 18.5d; aPD-1 15d; GSI+aPD-1 10d; RT 35d; RT+ GSI 41d; RT+aPD-1 43d; RT+aPD-1+ GSI 98.5d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (D) Lungs were collected from EO771 tumor–bearing mice (n = 4–7 per group) treated as described above and sacrificed either at day 10 or at the survival endpoint. Tumor metastases were quantified using HALO image analysis, calculated as metastatic area divided by total lung area. Bars represent mean ± SD. *P<0.05, using one-way ANOVA followed by Tukey post-hoc comparisons.

    Journal: bioRxiv

    Article Title: A Novel Therapeutic Approach: Notch Inhibition Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment

    doi: 10.64898/2025.12.30.696685

    Figure Lengend Snippet: (A). Tumor cells were implanted into the flank (1 x 10 6 9464D) or mammary fat pad (1 x 10 5 EO771) of C57BL/6 mice, enrolled when tumors reached 0.15-0.2mm 3 . Mice were treated as per the schema and sacrificed when tumors reached a size 1.5cm 3 . (B) The Kaplan-Meier survival curve of mice and tumor volume growth curve of 9464D tumor. Median Survival: Control 12d; IgG 10d; GSI 10d; aPD-1 10d; aPD-1+ GSI 10d; RT 37d; RT+ GSI 50d; RT+aPD-1 46d; RT+aPD-1+AL101 87d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (C) The Kaplan-Meier survival curve of mice and tumor volume growth curve of EO771 tumor Median Survival: Control: 14d; IgG 14.5d; GSI 18.5d; aPD-1 15d; GSI+aPD-1 10d; RT 35d; RT+ GSI 41d; RT+aPD-1 43d; RT+aPD-1+ GSI 98.5d. Curve comparison by Log-rank (Mantel-Cox) test. P<0.0001. (D) Lungs were collected from EO771 tumor–bearing mice (n = 4–7 per group) treated as described above and sacrificed either at day 10 or at the survival endpoint. Tumor metastases were quantified using HALO image analysis, calculated as metastatic area divided by total lung area. Bars represent mean ± SD. *P<0.05, using one-way ANOVA followed by Tukey post-hoc comparisons.

    Article Snippet: EO771 cells (purchased from ATCC) and the 9464D cells (derived from a TH-MYCN transgenic neuroblastoma mouse, obtained as a gift from Dr.

    Techniques: Control, Comparison

    (A) UMAPs showing M1-like and M2-like macrophage states across treatments in 9464D tumor scRNA-seq. (B) Proportion of M1- and M2-like macrophages by treatment group (C) Expression of classical M1 (Il1b, Tnf) and M2 (Mrc1, Mgl2) markers. (D) M-MDSC module scores increase following RT + aPD-1 + GSI (E) Changes in the proportion of M1 and M2 macrophages subpopulation and Myeloid-derived suppressor cells (MDSC) subpopulations by flow cytometry in 9464D tumor (F) Changes in the proportion of M1 and M2 macrophages subpopulation and MDSC subpopulations by flow cytometry in EO771 tumor. Bars represent the mean. Each dot represents one animal. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 using one-way ANOVA followed by Tukey post-hoc comparisons.

    Journal: bioRxiv

    Article Title: A Novel Therapeutic Approach: Notch Inhibition Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment

    doi: 10.64898/2025.12.30.696685

    Figure Lengend Snippet: (A) UMAPs showing M1-like and M2-like macrophage states across treatments in 9464D tumor scRNA-seq. (B) Proportion of M1- and M2-like macrophages by treatment group (C) Expression of classical M1 (Il1b, Tnf) and M2 (Mrc1, Mgl2) markers. (D) M-MDSC module scores increase following RT + aPD-1 + GSI (E) Changes in the proportion of M1 and M2 macrophages subpopulation and Myeloid-derived suppressor cells (MDSC) subpopulations by flow cytometry in 9464D tumor (F) Changes in the proportion of M1 and M2 macrophages subpopulation and MDSC subpopulations by flow cytometry in EO771 tumor. Bars represent the mean. Each dot represents one animal. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 using one-way ANOVA followed by Tukey post-hoc comparisons.

    Article Snippet: EO771 cells (purchased from ATCC) and the 9464D cells (derived from a TH-MYCN transgenic neuroblastoma mouse, obtained as a gift from Dr.

    Techniques: Expressing, Derivative Assay, Flow Cytometry

    (A) Triple therapy enhances DC activation and antigen-presentation gene expression in 9464D tumor scRNA-seq. (B) Changes in the proportion of DC and CD103+DC proportion by flowcytometry in 9464D tumor. (C) Changes in the proportion of DC and CD103+DC proportion by flowcytometry in EO771 tumor. Bars represent mean, each dot represents one animal. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 using one-way ANOVA followed by Tukey post-hoc comparisons.

    Journal: bioRxiv

    Article Title: A Novel Therapeutic Approach: Notch Inhibition Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment

    doi: 10.64898/2025.12.30.696685

    Figure Lengend Snippet: (A) Triple therapy enhances DC activation and antigen-presentation gene expression in 9464D tumor scRNA-seq. (B) Changes in the proportion of DC and CD103+DC proportion by flowcytometry in 9464D tumor. (C) Changes in the proportion of DC and CD103+DC proportion by flowcytometry in EO771 tumor. Bars represent mean, each dot represents one animal. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 using one-way ANOVA followed by Tukey post-hoc comparisons.

    Article Snippet: EO771 cells (purchased from ATCC) and the 9464D cells (derived from a TH-MYCN transgenic neuroblastoma mouse, obtained as a gift from Dr.

    Techniques: Activation Assay, Immunopeptidomics, Gene Expression

    9464D cells or EO771 were implanted into NCr nude mice and treated per the schema in . Mice were sacrificed when tumors reached a size >1.5 cm 3 . (A) The Kaplan-Meier survival curve of mice and tumor volume growth curve of athymic nude mice 9464D tumor. (B) The Kaplan-Meier survival curve of mice and tumor volume growth curve, as well as lung metastasis of athymic nude mice EO771 tumor. Comparison by Log-rank (Mantel-Cox) test and one-way ANOVA.

    Journal: bioRxiv

    Article Title: A Novel Therapeutic Approach: Notch Inhibition Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment

    doi: 10.64898/2025.12.30.696685

    Figure Lengend Snippet: 9464D cells or EO771 were implanted into NCr nude mice and treated per the schema in . Mice were sacrificed when tumors reached a size >1.5 cm 3 . (A) The Kaplan-Meier survival curve of mice and tumor volume growth curve of athymic nude mice 9464D tumor. (B) The Kaplan-Meier survival curve of mice and tumor volume growth curve, as well as lung metastasis of athymic nude mice EO771 tumor. Comparison by Log-rank (Mantel-Cox) test and one-way ANOVA.

    Article Snippet: EO771 cells (purchased from ATCC) and the 9464D cells (derived from a TH-MYCN transgenic neuroblastoma mouse, obtained as a gift from Dr.

    Techniques: Comparison